{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:30:04Z","timestamp":1768591804574,"version":"3.49.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["SFH180614346729"],"award-info":[{"award-number":["SFH180614346729"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","award":["18\/18"],"award-info":[{"award-number":["18\/18"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["2018-1DEV46-NPR03"],"award-info":[{"award-number":["2018-1DEV46-NPR03"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>People who inject drugs (PWID) are disproportionately burdened with hepatitis C virus (HCV) infection in South Africa (SA). Transmission dynamics can be inferred using phylogenetic clustering to inform prevention interventions. We utilized Core-E2 sequences and demographic data to investigate factors associated with HCV phylogenetic clustering among PWID and men who have sex with men (MSM) who inject drugs in SA. Previously genotyped samples (n\u2009=\u2009285) that met the selection criteria were extracted, amplified, and Sanger sequenced. Phylogenetic trees were inferred using maximum likelihood implemented in RAxML (Cipres Gateway). Transmission clusters were determined in Clusterpicker using a 90% bootstrap threshold and a genetic distance cut-off on genetic similarity of \u22643.5%. Factors associated with clustering were assessed using logistic regression. Phylogenetic clustering of Core-E2 sequences was observed for 55% (78 of 141) of participant samples that were successfully sequenced, including 50 (64.1%) with genotype 1a and 28 (35.9%) with genotype 3a. Twelve clusters were identified, including six clusters each for genotypes 1a and 3a. Among genotype 1a, the cluster size ranged from 3 to 15 participants. Among genotype 3a, the cluster size ranged from 3 to 9 participants. Clustering among the mixed ancestry group in Cape Town was noted for ages 18\u201355. Factors independently associated with phylogenetic clustering included sharing a needle (adjusted odds ratio [aOR] 4.02, 95% confidence interval [CI] 1.08\u201314.87, p\u2009=\u20090.037), age\u2009\u2265\u200929 years (aOR 3.00, 95% CI 1.22\u20137.37, p\u2009=\u20090.016), and mixed ancestry race (aOR 6.11, 95% CI 1.87\u201319.95, p\u2009=\u20090.003). These data highlight the urgent need to reduce transmission by providing sufficient sterile needles and syringes and tailored education to prevent HCV transmission among older, experienced PWID.<\/jats:p>","DOI":"10.1371\/journal.pone.0336614","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T18:32:30Z","timestamp":1764613950000},"page":"e0336614","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors associated with phylogenetic clustering of hepatitis C virus, mainly among people who inject drugs who access HIV prevention services in South Africa, 2016\u20132017"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0294-0720","authenticated-orcid":true,"given":"Nkosenhle L.","family":"Ndlovu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Scheibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Hausler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Sonderup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Wendy","family":"Spearman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawie","family":"Nel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-3811","authenticated-orcid":true,"given":"Jason T.","family":"Blackard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishi","family":"Prabdial-Sing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"3","key":"pone.0336614.ref001","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"S Blach","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"pone.0336614.ref002","unstructured":"Polaris T, Hcv O. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study."},{"key":"pone.0336614.ref003","volume-title":"Global hepatitis report 2024: action for access in low-and middle-income countries","author":"Organization WH","year":"2024"},{"issue":"5","key":"pone.0336614.ref004","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","article-title":"Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine","volume":"12","author":"J Grebely","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"pone.0336614.ref005","author":"WHO"},{"key":"pone.0336614.ref006","doi-asserted-by":"crossref","first-page":"100442","DOI":"10.1016\/j.epidem.2021.100442","article-title":"Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression","volume":"34","author":"LA Kondili","year":"2021","journal-title":"Epidemics"},{"key":"pone.0336614.ref007","author":"D Smith","year":"2022"},{"issue":"2","key":"pone.0336614.ref008","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4254\/wjh.v10.i2.186","article-title":"Hepatitis C virus: Morphogenesis, infection and therapy","volume":"10","author":"VA Morozov","year":"2018","journal-title":"World J Hepatol"},{"key":"pone.0336614.ref009","author":"WHO","year":"2021"},{"issue":"12","key":"pone.0336614.ref010","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.7196\/SAMJ.2017.v107i12.12623","article-title":"Hepatitis C: A South African literature review and results from a burden of disease study among a cohort of drug-using men who have sex with men in Cape Town, South Africa","volume":"107","author":"NP Semugoma","year":"2017","journal-title":"S Afr Med J"},{"issue":"1","key":"pone.0336614.ref011","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-019-0298-2","article-title":"Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: Findings from a three-city cross-sectional survey","volume":"16","author":"A Scheibe","year":"2019","journal-title":"Harm Reduct J"},{"issue":"1","key":"pone.0336614.ref012","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-05359-y","article-title":"Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey","volume":"20","author":"A Scheibe","year":"2020","journal-title":"BMC Infect Dis"},{"key":"pone.0336614.ref013","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.meegid.2015.11.028","article-title":"HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection","volume":"37","author":"SR Bartlett","year":"2016","journal-title":"Infect Genet Evol"},{"key":"pone.0336614.ref014","doi-asserted-by":"crossref","unstructured":"Sonderup MW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, et al. Viral hepatitis in sub-Saharan Africa 2 Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030 [Internet]. 2017.","DOI":"10.1016\/S2468-1253(17)30249-2"},{"issue":"11","key":"pone.0336614.ref015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/jvh.12571","article-title":"Hepatitis C genotype distribution in patient and blood donor samples in South Africa for the period 2008\u20132012","volume":"23","author":"N Prabdial-Sing","year":"2016","journal-title":"J Viral Hepat"},{"issue":"5","key":"pone.0336614.ref016","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/jvh.12652","article-title":"A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies","volume":"24","author":"SR Bartlett","year":"2017","journal-title":"J Viral Hepat"},{"issue":"11","key":"pone.0336614.ref017","first-page":"1116","article-title":"A model-based estimate of HIV infectivity via needle sharing","volume":"5","author":"EH Kaplan","year":"1992","journal-title":"J Acquir Immune Defic Syndr (1988)"},{"issue":"5","key":"pone.0336614.ref018","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/hep.27310","article-title":"Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada","volume":"60","author":"B Jacka","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"pone.0336614.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050050","article-title":"Episodic sexual transmission of HIV revealed by molecular phylodynamics","volume":"5","author":"F Lewis","year":"2008","journal-title":"PLoS Med"},{"key":"pone.0336614.ref020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.drugalcdep.2015.04.005","article-title":"Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada","volume":"152","author":"EB Cunningham","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"pone.0336614.ref021","unstructured":"Lamoury F, Bartlett S, Jacka B, Wong A, Matthews GV, Grebely J, et al. Use of a novel sequence analysis method of the 5\u2019UTR-HVR1 region for genotyping and molecular epidemiology of HCV in the ATAHC study. 20th International Symposium on Hepatitis C Virus and Related Viruses; 2013; Melbourne, Australia. 2013."},{"issue":"7","key":"pone.0336614.ref022","article-title":"The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis","volume":"10","author":"FMJ Lamoury","year":"2015","journal-title":"PLoS One"},{"key":"pone.0336614.ref023","article-title":"MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform","author":"K Katoh","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"pone.0336614.ref024","article-title":"The hepatitis C sequence database in Los Alamos","volume":"36","author":"C Kuiken","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"pone.0336614.ref025","author":"AM Alzohairy","year":"1991"},{"key":"pone.0336614.ref026","doi-asserted-by":"crossref","unstructured":"Miller MA, Pfeiffer W, Schwartz T. Creating the CIPRES Science Gateway for Inference of Large Phylogenetic Trees. 2010.","DOI":"10.1109\/GCE.2010.5676129"},{"issue":"9","key":"pone.0336614.ref027","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/bioinformatics\/btu032","article-title":"Jmodeltest.org: Selection of nucleotide substitution models on the cloud","volume":"30","author":"JM Santorum","year":"2014","journal-title":"Bioinformatics"},{"key":"pone.0336614.ref028","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-317","article-title":"Automated analysis of phylogenetic clusters","volume":"14","author":"M Ragonnet-Cronin","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"pone.0336614.ref029","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz357","article-title":"Evolview v3: A webserver for visualization, annotation, and management of phylogenetic trees","volume":"47","author":"B Subramanian","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0336614.ref030","author":"A Rambaut","year":"2009"},{"key":"pone.0336614.ref031","unstructured":"STEP-UP project, harm reduction initiatives. TB\/HIV care."},{"key":"pone.0336614.ref032","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12954-015-0069-7","article-title":"Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan","volume":"12","author":"WA Zule","year":"2015","journal-title":"Harm Reduct J"},{"key":"pone.0336614.ref033","unstructured":"The Global Fund to Fight AIDS Tuberculsosis and Malaria. Technical Brief. Harm Reduction for People Who Use Drugs: Priorities for Investment and Increased Impact in HIV programming. 2023 - 2025. 2022;(November 2022)."},{"key":"pone.0336614.ref034","first-page":"12","author":"For Disease Control C, of HIV D, Prevention A","year":"2020"},{"issue":"12","key":"pone.0336614.ref035","article-title":"Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review","volume":"5","author":"S Larney","year":"2017","journal-title":"Lancet Glob Heal"},{"issue":"1","key":"pone.0336614.ref036","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews","volume":"17","author":"RM Fernandes","year":"2017","journal-title":"BMC Public Health"},{"key":"pone.0336614.ref037","author":"INHSU","year":"2021"},{"issue":"1","key":"pone.0336614.ref038","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"H Hagan","year":"2011","journal-title":"J Infect Dis"},{"issue":"2","key":"pone.0336614.ref039","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(18)30292-3","article-title":"Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs","volume":"6","author":"H Reddon","year":"2019","journal-title":"Lancet HIV"},{"issue":"1","key":"pone.0336614.ref040","article-title":"Risk factors associated with infection of blood-borne virus among people who used methamphetamine","volume":"20","author":"Y Cai","year":"2020","journal-title":"BMC Infect Dis"},{"key":"pone.0336614.ref041","unstructured":"Eligh J. Commodity report the evolution of methamphetamine markets in eastern and southern africa a synthetic age. 2021."},{"key":"pone.0336614.ref042","author":"A Leoni"},{"issue":"10003","key":"pone.0336614.ref043","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"A Schweitzer","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"pone.0336614.ref044","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/09581596.2018.1443204","article-title":"Empathic response and no need for perfection: reflections on harm reduction engagement in South Africa","volume":"28","author":"A Versfeld","year":"2018","journal-title":"Critical Public Health"},{"issue":"7053","key":"pone.0336614.ref045","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nature04077","article-title":"Unravelling hepatitis C virus replication from genome to function","volume":"436","author":"BD Lindenbach","year":"2005","journal-title":"Nature"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T18:32:40Z","timestamp":1764613960000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336614"}},"subtitle":[],"editor":[{"given":"Syed Hani","family":"Abidi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0336614","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}